Therefore, there is evidence that suggest that NF1 mutations in lung cancer con also activate Ras signaling pathway, playing a key role in the incorrect signal transduction, proliferation and malignant transformation (Reuter et al., 2000). The gene discussed is NF1; the disease is lung carcinoma.